在直肠癌中,透过门与拉皮镜整体隔膜切除和3年无病生存期:TaLaR随机临床试验
Ziwei Zeng1, Shuangling Luo1, Hong Zhang2
1Department of General Surgery (Colorectal Surgery), Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.
JAMA
|January 23, 2025
概括
与腹腔镜TME相比,在直肠癌患者中,全腹腔切除 (TME) 显示不低于3年无病存活率. 这一发现支持透过门的TME作为可行的瘤治疗选择.
科学领域:
- 外科瘤学
- 胃肠病学
- 临床试验
背景情况:
- 短期结果有利于通过门切除全腹膜切除术 (TME) 而不是腹腔镜切除术.
- 需要进一步研究透过门的TME的长期瘤结果.
研究的目的:
- 在中低度直肠癌患者中比较透过TME和腹腔镜TME的3年无病生存期.
主要方法:
- 一个随机的,开放的,非劣势的,涉及1115名患者的临床试验.
- 参与者被随机分配到透过门的TME或腹腔镜的TME.
- 主要终点是3年无病生存期,非劣势率为-10%.
主要成果:
- 经过门的TME的3年无病生存率为82. 1%,而腹腔镜的TME为79. 4% (差异为2. 7%).
- 经过门的TME达到无病生存的非劣势差.
- 在3年内,局部复发率为3. 6% (透鼻TME) 和4. 4% (腹腔镜TME).
结论:
- 在中低度的直肠癌中,通过门的TME在3年无病生存期方面与腹腔镜的TME不相差.
- 这项研究支持透过门的TME作为一种有效的瘤治疗选择.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


